A carregar...
PP2A: A Promising Biomarker and Therapeutic Target in Endometrial Cancer
Over the last decade, the use of targeted therapies has immensely increased in the treatment of cancer. However, treatment for endometrial carcinomas (ECs) has lagged behind, although potential molecular markers have been identified. This is particularly problematic for the type II ECs, since these...
Na minha lista:
| Publicado no: | Front Oncol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6558005/ https://ncbi.nlm.nih.gov/pubmed/31214504 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.00462 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|